
Metamik 250mg Injection
Marketer
Metamorf Lifesciences
Salt Composition
Amikacin (250mg)
Overview Metamik 250mg Injection
Cefamandole 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary system, bones, joints, lungs (such as pneumonia), brain, and bloodstream. This antibiotic is also administered prophylactically to hospitalized patients. Its mechanism involves inhibiting bacterial growth. Administered intravenously or intramuscularly by a healthcare professional only, this medication requires regular, evenly-spaced dosing as directed. Complete the prescribed course, even with symptom improvement, to prevent relapse. Common side effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or lack of improvement warrant medical attention. High doses may rarely cause dizziness, kidney impairment, and hearing problems, necessitating close monitoring, including regular kidney and hearing assessments, and urinalysis. Use during pregnancy is contraindicated; inform your physician if pregnant, planning pregnancy, or breastfeeding.
Uses of Metamik 250mg Injection
Infections caused by bacteria
Major Benefits of Metamik 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Metamik 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Metamik 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Metamik 250mg Injection works:
Bio-Mycin 250mg Injection, an antibacterial agent, inhibits bacterial proliferation by disrupting the synthesis of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Metamik 250mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Metamik 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use only when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Use of Metamik 250mg Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
The administration of Metamik 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Administering Metamik 250mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Metamik 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of the 250mg Metamik Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Metamik 250mg Injection :
Omitting a scheduled dose of Metamik 250mg Injection warrants immediate physician consultation.
Facts to Know About Metamik 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
